NCT00576342View on ClinicalTrials.gov

Patient Preference Study

PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

AL-3862+timolol ophthalmic suspension

DRUG

Dorzolamide+timolol ophthalmic solution

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00576342 - Patient Preference Study | Biotech Hunter | Biotech Hunter